AAAAAA
Results: 1-25/27
Authors:
Edler, L
Citation: L. Edler, Overview of phase I trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 1-34
Authors:
O'Quigley, J
Citation: J. O'Quigley, Dose-finding designs using continual reassessment method, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 35-72
Authors:
Storer, BE
Citation: Be. Storer, Choosing a phase I design, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 73-91
Authors:
Green, S
Citation: S. Green, Overview of phase II clinical trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 93-103
Authors:
Petroni, GR
Conaway, MR
Citation: Gr. Petroni et Mr. Conaway, Designs based on toxicity and response, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 105-118
Authors:
Liu, PY
Citation: Py. Liu, Phase II selection designs, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 119-127
Authors:
Shuster, JJ
Citation: Jj. Shuster, Power and sample size for phase III clinical trials of survival, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 129-147
Authors:
George, SL
Citation: Sl. George, Multiple treatment trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 149-159
Authors:
Green, S
Citation: S. Green, Factorial designs with time-to-event end points, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 161-171
Authors:
Simon, R
Citation: R. Simon, Therapeutic equivalence trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 173-187
Authors:
Dignam, JJ
Bryant, J
Wieand, HS
Citation: Jj. Dignam et al., Early stopping of cancer clinical trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 189-209
Authors:
Whitehead, J
Citation: J. Whitehead, Use of the triangular test in sequential clinical trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 211-228
Authors:
Cole, BF
Citation: Bf. Cole, Design and analysis considerations for complementary outcomes, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 229-248
Authors:
Zee, BC
Osoba, D
Citation: Bc. Zee et D. Osoba, Health-related quality-of-life outcomes, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 249-267
Authors:
Troxel, AB
Moinpour, CM
Citation: Ab. Troxel et Cm. Moinpour, Statistical analysis of quality of life, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 269-289
Authors:
Lyman, GH
Citation: Gh. Lyman, Economic analysis of cancer clinical trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 291-320
Authors:
Schumacher, M
Hollander, N
Schwarzer, G
Sauerbrei, W
Citation: M. Schumacher et al., Prognostic factor studies, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 321-378
Authors:
Ulm, K
Nekarda, H
Gerein, P
Berger, U
Citation: K. Ulm et al., Statistical methods to identify prognostic factors, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 379-395
Authors:
O'Quigley, J
Xu, RH
Citation: J. O'Quigley et Rh. Xu, Explained variation in proportional hazards regression, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 397-409
Authors:
Thall, PF
Estey, EH
Citation: Pf. Thall et Eh. Estey, Graphical methods for evaluating covariate effects in the Cox model, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 411-432
Authors:
Sasieni, PD
Winnett, A
Citation: Pd. Sasieni et A. Winnett, Graphical approaches to exploring the effects of prognostic factors on survival, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 433-456
Authors:
LeBlanc, M
Citation: M. Leblanc, Tree-based methods for prognostic stratification, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 457-472
Authors:
Siu, LL
Tannock, IF
Citation: Ll. Siu et If. Tannock, Problems in interpreting clinical trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 473-490
Authors:
Anderson, JR
Citation: Jr. Anderson, Commonly misused approaches in the analysis of cancer clinical trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 491-502
Authors:
Pater, JL
Citation: Jl. Pater, Dose-intensity analysis, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 503-511